Quick Answer
Liminatus Pharma, Inc. reported Total Assets of $512.8 thousand for fiscal year 2025.
Liminatus Pharma, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $512.8K | -90.5% |
| 2024 | $5.41M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.34M | — | -29.7% |
| June 30, 2025 | $1.91M | — | -64.7% |
| December 31, 2024 | $5.41M | — | — |
- Liminatus Pharma, Inc. showed a decrease of -90.5% in Total Assets compared to the prior fiscal year.
- Over the 2024–2025 period, Liminatus Pharma, Inc.’s total assets has declined by 90.5% (from $5.41 million to $512.8 thousand).
- The most recent figure is from Liminatus Pharma, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: